BioCentury
ARTICLE | Company News

Zydus sales and marketing update

December 15, 2014 8:00 AM UTC

Zydus launched Exemptia, a biosimilar of adalimumab, in India to treat autoimmune disorders including rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spon...